CS237487B1 - 2-aminoethyletheres derived from 2-substituted 6,11-dihydrodibenzo/b,e/thiepin-11-oles and salts of the same - Google Patents
2-aminoethyletheres derived from 2-substituted 6,11-dihydrodibenzo/b,e/thiepin-11-oles and salts of the same Download PDFInfo
- Publication number
- CS237487B1 CS237487B1 CS149684A CS149684A CS237487B1 CS 237487 B1 CS237487 B1 CS 237487B1 CS 149684 A CS149684 A CS 149684A CS 149684 A CS149684 A CS 149684A CS 237487 B1 CS237487 B1 CS 237487B1
- Authority
- CS
- Czechoslovakia
- Prior art keywords
- dihydrodibenzo
- chloro
- salts
- thiepin
- formula
- Prior art date
Links
- 150000003839 salts Chemical class 0.000 title claims abstract description 7
- VZCYOOQTPOCHFL-UPHRSURJSA-N maleic acid Chemical compound OC(=O)\C=C/C(O)=O VZCYOOQTPOCHFL-UPHRSURJSA-N 0.000 claims abstract description 9
- VZCYOOQTPOCHFL-UHFFFAOYSA-N trans-butenedioic acid Natural products OC(=O)C=CC(O)=O VZCYOOQTPOCHFL-UHFFFAOYSA-N 0.000 claims abstract description 9
- OFOBLEOULBTSOW-UHFFFAOYSA-N Propanedioic acid Natural products OC(=O)CC(O)=O OFOBLEOULBTSOW-UHFFFAOYSA-N 0.000 claims abstract description 8
- 239000011976 maleic acid Substances 0.000 claims abstract description 8
- 239000000126 substance Substances 0.000 claims abstract description 5
- 239000000460 chlorine Substances 0.000 claims abstract description 4
- 229910052801 chlorine Inorganic materials 0.000 claims abstract description 4
- 150000007524 organic acids Chemical class 0.000 claims abstract description 4
- 235000005985 organic acids Nutrition 0.000 claims abstract description 4
- 125000001309 chloro group Chemical group Cl* 0.000 claims abstract description 3
- 125000002496 methyl group Chemical group [H]C([H])([H])* 0.000 claims abstract description 3
- GXVUZYLYWKWJIM-UHFFFAOYSA-N 2-(2-aminoethoxy)ethanamine Chemical compound NCCOCCN GXVUZYLYWKWJIM-UHFFFAOYSA-N 0.000 claims 1
- 238000012937 correction Methods 0.000 claims 1
- -1 organic base acids Chemical class 0.000 abstract description 12
- 150000001875 compounds Chemical class 0.000 abstract description 11
- 125000006016 2-bromoethoxy group Chemical group 0.000 abstract description 10
- 238000000034 method Methods 0.000 abstract description 5
- 238000006386 neutralization reaction Methods 0.000 abstract description 5
- GLUUGHFHXGJENI-UHFFFAOYSA-N Piperazine Chemical compound C1CNCCN1 GLUUGHFHXGJENI-UHFFFAOYSA-N 0.000 abstract description 4
- 150000001412 amines Chemical class 0.000 abstract description 4
- 238000006467 substitution reaction Methods 0.000 abstract description 4
- RALRVIPTUXSBPO-UHFFFAOYSA-N 4-[4-chloro-3-(trifluoromethyl)phenyl]piperidin-4-ol Chemical compound C=1C=C(Cl)C(C(F)(F)F)=CC=1C1(O)CCNCC1 RALRVIPTUXSBPO-UHFFFAOYSA-N 0.000 abstract description 2
- 239000002253 acid Substances 0.000 abstract description 2
- 208000026935 allergic disease Diseases 0.000 abstract description 2
- 230000003288 anthiarrhythmic effect Effects 0.000 abstract description 2
- 239000000739 antihistaminic agent Substances 0.000 abstract description 2
- 208000015181 infectious disease Diseases 0.000 abstract description 2
- 230000000813 microbial effect Effects 0.000 abstract description 2
- 230000033764 rhythmic process Effects 0.000 abstract description 2
- 229940066768 systemic antihistamines aminoalkyl ethers Drugs 0.000 abstract description 2
- 238000002560 therapeutic procedure Methods 0.000 abstract description 2
- JLRRONOEUGUFFI-UHFFFAOYSA-N 6,11-dihydrobenzo[c][1]benzothiepin-11-ol Chemical class C1SC2=CC=CC=C2C(O)C2=CC=CC=C21 JLRRONOEUGUFFI-UHFFFAOYSA-N 0.000 abstract 1
- 208000020446 Cardiac disease Diseases 0.000 abstract 1
- 239000004480 active ingredient Substances 0.000 abstract 1
- 239000003416 antiarrhythmic agent Substances 0.000 abstract 1
- 229940125715 antihistaminic agent Drugs 0.000 abstract 1
- 239000004599 antimicrobial Substances 0.000 abstract 1
- 239000003814 drug Substances 0.000 abstract 1
- 229940079593 drug Drugs 0.000 abstract 1
- 208000019622 heart disease Diseases 0.000 abstract 1
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 32
- UHOVQNZJYSORNB-UHFFFAOYSA-N Benzene Chemical compound C1=CC=CC=C1 UHOVQNZJYSORNB-UHFFFAOYSA-N 0.000 description 30
- 239000000203 mixture Substances 0.000 description 21
- BWHMMNNQKKPAPP-UHFFFAOYSA-L potassium carbonate Chemical compound [K+].[K+].[O-]C([O-])=O BWHMMNNQKKPAPP-UHFFFAOYSA-L 0.000 description 16
- OKKJLVBELUTLKV-UHFFFAOYSA-N Methanol Chemical compound OC OKKJLVBELUTLKV-UHFFFAOYSA-N 0.000 description 15
- HEDRZPFGACZZDS-UHFFFAOYSA-N Chloroform Chemical compound ClC(Cl)Cl HEDRZPFGACZZDS-UHFFFAOYSA-N 0.000 description 14
- RTZKZFJDLAIYFH-UHFFFAOYSA-N Diethyl ether Chemical compound CCOCC RTZKZFJDLAIYFH-UHFFFAOYSA-N 0.000 description 10
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 10
- FWWOWPGPERBCNJ-UHFFFAOYSA-N 2-hydroxy-4-(2-hydroxyethoxy)-4-oxobutanoic acid Chemical compound OCCOC(=O)CC(O)C(O)=O FWWOWPGPERBCNJ-UHFFFAOYSA-N 0.000 description 9
- HEMHJVSKTPXQMS-UHFFFAOYSA-M Sodium hydroxide Chemical compound [OH-].[Na+] HEMHJVSKTPXQMS-UHFFFAOYSA-M 0.000 description 9
- 229910000027 potassium carbonate Inorganic materials 0.000 description 8
- MUBZPKHOEPUJKR-UHFFFAOYSA-N Oxalic acid Chemical compound OC(=O)C(O)=O MUBZPKHOEPUJKR-UHFFFAOYSA-N 0.000 description 6
- 238000001816 cooling Methods 0.000 description 6
- 125000001301 ethoxy group Chemical group [H]C([H])([H])C([H])([H])O* 0.000 description 6
- VEXZGXHMUGYJMC-UHFFFAOYSA-N Hydrochloric acid Chemical compound Cl VEXZGXHMUGYJMC-UHFFFAOYSA-N 0.000 description 5
- 239000000047 product Substances 0.000 description 5
- CSCPPACGZOOCGX-UHFFFAOYSA-N Acetone Chemical compound CC(C)=O CSCPPACGZOOCGX-UHFFFAOYSA-N 0.000 description 4
- CSNNHWWHGAXBCP-UHFFFAOYSA-L Magnesium sulfate Chemical compound [Mg+2].[O-][S+2]([O-])([O-])[O-] CSNNHWWHGAXBCP-UHFFFAOYSA-L 0.000 description 4
- QAOWNCQODCNURD-UHFFFAOYSA-N Sulfuric acid Chemical compound OS(O)(=O)=O QAOWNCQODCNURD-UHFFFAOYSA-N 0.000 description 4
- 230000002401 inhibitory effect Effects 0.000 description 4
- 239000000155 melt Substances 0.000 description 4
- PVOAHINGSUIXLS-UHFFFAOYSA-N 1-Methylpiperazine Chemical compound CN1CCNCC1 PVOAHINGSUIXLS-UHFFFAOYSA-N 0.000 description 3
- YMWUJEATGCHHMB-UHFFFAOYSA-N Dichloromethane Chemical compound ClCCl YMWUJEATGCHHMB-UHFFFAOYSA-N 0.000 description 3
- KWYUFKZDYYNOTN-UHFFFAOYSA-M Potassium hydroxide Chemical compound [OH-].[K+] KWYUFKZDYYNOTN-UHFFFAOYSA-M 0.000 description 3
- 241000191967 Staphylococcus aureus Species 0.000 description 3
- 238000006243 chemical reaction Methods 0.000 description 3
- 230000000694 effects Effects 0.000 description 3
- 239000000706 filtrate Substances 0.000 description 3
- 238000002844 melting Methods 0.000 description 3
- 230000008018 melting Effects 0.000 description 3
- 238000002360 preparation method Methods 0.000 description 3
- 238000001953 recrystallisation Methods 0.000 description 3
- FOZVXADQAHVUSV-UHFFFAOYSA-N 1-bromo-2-(2-bromoethoxy)ethane Chemical class BrCCOCCBr FOZVXADQAHVUSV-UHFFFAOYSA-N 0.000 description 2
- LDLCZOVUSADOIV-UHFFFAOYSA-N 2-bromoethanol Chemical compound OCCBr LDLCZOVUSADOIV-UHFFFAOYSA-N 0.000 description 2
- WFCSWCVEJLETKA-UHFFFAOYSA-N 2-piperazin-1-ylethanol Chemical compound OCCN1CCNCC1 WFCSWCVEJLETKA-UHFFFAOYSA-N 0.000 description 2
- VHUUQVKOLVNVRT-UHFFFAOYSA-N Ammonium hydroxide Chemical compound [NH4+].[OH-] VHUUQVKOLVNVRT-UHFFFAOYSA-N 0.000 description 2
- 241000700198 Cavia Species 0.000 description 2
- 241000194032 Enterococcus faecalis Species 0.000 description 2
- NTYJJOPFIAHURM-UHFFFAOYSA-N Histamine Chemical compound NCCC1=CN=CN1 NTYJJOPFIAHURM-UHFFFAOYSA-N 0.000 description 2
- CPELXLSAUQHCOX-UHFFFAOYSA-N Hydrogen bromide Chemical compound Br CPELXLSAUQHCOX-UHFFFAOYSA-N 0.000 description 2
- 241000699670 Mus sp. Species 0.000 description 2
- 241000700159 Rattus Species 0.000 description 2
- UIIMBOGNXHQVGW-UHFFFAOYSA-M Sodium bicarbonate Chemical compound [Na+].OC([O-])=O UIIMBOGNXHQVGW-UHFFFAOYSA-M 0.000 description 2
- 241001045770 Trichophyton mentagrophytes Species 0.000 description 2
- 230000007059 acute toxicity Effects 0.000 description 2
- 231100000403 acute toxicity Toxicity 0.000 description 2
- QGZKDVFQNNGYKY-UHFFFAOYSA-N ammonia Natural products N QGZKDVFQNNGYKY-UHFFFAOYSA-N 0.000 description 2
- 230000001387 anti-histamine Effects 0.000 description 2
- 125000001495 ethyl group Chemical group [H]C([H])([H])C([H])([H])* 0.000 description 2
- 238000000338 in vitro Methods 0.000 description 2
- 229910052943 magnesium sulfate Inorganic materials 0.000 description 2
- 235000019341 magnesium sulphate Nutrition 0.000 description 2
- 244000005700 microbiome Species 0.000 description 2
- MUBZPKHOEPUJKR-UHFFFAOYSA-M oxalate(1-) Chemical compound OC(=O)C([O-])=O MUBZPKHOEPUJKR-UHFFFAOYSA-M 0.000 description 2
- 235000006408 oxalic acid Nutrition 0.000 description 2
- LOUPRKONTZGTKE-LHHVKLHASA-N quinidine Chemical compound C([C@H]([C@H](C1)C=C)C2)C[N@@]1[C@H]2[C@@H](O)C1=CC=NC2=CC=C(OC)C=C21 LOUPRKONTZGTKE-LHHVKLHASA-N 0.000 description 2
- XFSBVAOIAHNAPC-XTHSEXKGSA-N 16-Ethyl-1alpha,6alpha,19beta-trimethoxy-4-(methoxymethyl)-aconitane-3alpha,8,10alpha,11,18alpha-pentol, 8-acetate 10-benzoate Chemical compound O([C@H]1[C@]2(O)C[C@H]3[C@@]45C6[C@@H]([C@@]([C@H]31)(OC(C)=O)[C@@H](O)[C@@H]2OC)[C@H](OC)[C@@H]4[C@]([C@@H](C[C@@H]5OC)O)(COC)CN6CC)C(=O)C1=CC=CC=C1 XFSBVAOIAHNAPC-XTHSEXKGSA-N 0.000 description 1
- JUOZATSMKDYYGH-UHFFFAOYSA-N 2-[1-(4-bromophenyl)-1-phenylethoxy]-n,n-dimethylethanamine;hydrochloride Chemical group [Cl-].C=1C=C(Br)C=CC=1C(C)(OCC[NH+](C)C)C1=CC=CC=C1 JUOZATSMKDYYGH-UHFFFAOYSA-N 0.000 description 1
- HEOKVTVEOGBPRI-UHFFFAOYSA-N 2-[4-[2-[(2-chloro-6,11-dihydrobenzo[c][1]benzothiepin-11-yl)oxy]ethyl]piperazin-1-yl]ethanol Chemical compound C1CN(CCO)CCN1CCOC1C2=CC(Cl)=CC=C2SCC2=CC=CC=C21 HEOKVTVEOGBPRI-UHFFFAOYSA-N 0.000 description 1
- 125000000954 2-hydroxyethyl group Chemical group [H]C([*])([H])C([H])([H])O[H] 0.000 description 1
- XFSBVAOIAHNAPC-UHFFFAOYSA-N Aconitin Natural products CCN1CC(C(CC2OC)O)(COC)C3C(OC)C(C(C45)(OC(C)=O)C(O)C6OC)C1C32C4CC6(O)C5OC(=O)C1=CC=CC=C1 XFSBVAOIAHNAPC-UHFFFAOYSA-N 0.000 description 1
- 241000588724 Escherichia coli Species 0.000 description 1
- CTQNGGLPUBDAKN-UHFFFAOYSA-N O-Xylene Chemical compound CC1=CC=CC=C1C CTQNGGLPUBDAKN-UHFFFAOYSA-N 0.000 description 1
- 241000235070 Saccharomyces Species 0.000 description 1
- VYPSYNLAJGMNEJ-UHFFFAOYSA-N Silicium dioxide Chemical compound O=[Si]=O VYPSYNLAJGMNEJ-UHFFFAOYSA-N 0.000 description 1
- 241000191940 Staphylococcus Species 0.000 description 1
- 241000194017 Streptococcus Species 0.000 description 1
- GUGOEEXESWIERI-UHFFFAOYSA-N Terfenadine Chemical compound C1=CC(C(C)(C)C)=CC=C1C(O)CCCN1CCC(C(O)(C=2C=CC=CC=2)C=2C=CC=CC=2)CC1 GUGOEEXESWIERI-UHFFFAOYSA-N 0.000 description 1
- 230000002378 acidificating effect Effects 0.000 description 1
- 229940039750 aconitine Drugs 0.000 description 1
- STDXGNLCJACLFY-UHFFFAOYSA-N aconitine Natural products CCN1CC2(COC)C(O)CC(O)C34C5CC6(O)C(OC)C(O)C(OC(=O)C)(C5C6OC(=O)c7ccccc7)C(C(OC)C23)C14 STDXGNLCJACLFY-UHFFFAOYSA-N 0.000 description 1
- 238000005904 alkaline hydrolysis reaction Methods 0.000 description 1
- 238000004458 analytical method Methods 0.000 description 1
- 239000000538 analytical sample Substances 0.000 description 1
- 238000010171 animal model Methods 0.000 description 1
- 230000000845 anti-microbial effect Effects 0.000 description 1
- 230000006793 arrhythmia Effects 0.000 description 1
- 206010003119 arrhythmia Diseases 0.000 description 1
- SLUNEGLMXGHOLY-UHFFFAOYSA-N benzene;hexane Chemical compound CCCCCC.C1=CC=CC=C1 SLUNEGLMXGHOLY-UHFFFAOYSA-N 0.000 description 1
- 230000036772 blood pressure Effects 0.000 description 1
- 238000009835 boiling Methods 0.000 description 1
- 150000004657 carbamic acid derivatives Chemical class 0.000 description 1
- 230000000747 cardiac effect Effects 0.000 description 1
- 239000003610 charcoal Substances 0.000 description 1
- 239000007795 chemical reaction product Substances 0.000 description 1
- 238000002512 chemotherapy Methods 0.000 description 1
- LOUPRKONTZGTKE-UHFFFAOYSA-N cinchonine Natural products C1C(C(C2)C=C)CCN2C1C(O)C1=CC=NC2=CC=C(OC)C=C21 LOUPRKONTZGTKE-UHFFFAOYSA-N 0.000 description 1
- 238000002425 crystallisation Methods 0.000 description 1
- 230000008025 crystallization Effects 0.000 description 1
- 238000007865 diluting Methods 0.000 description 1
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 1
- 229950000472 embramine Drugs 0.000 description 1
- 125000003754 ethoxycarbonyl group Chemical group C(=O)(OCC)* 0.000 description 1
- MHBJYKMWVCDLPD-UHFFFAOYSA-N ethyl 4-(2-hydroxyethyl)piperazine-1-carboxylate Chemical compound CCOC(=O)N1CCN(CCO)CC1 MHBJYKMWVCDLPD-UHFFFAOYSA-N 0.000 description 1
- LNOQURRKNJKKBU-UHFFFAOYSA-N ethyl piperazine-1-carboxylate Chemical compound CCOC(=O)N1CCNCC1 LNOQURRKNJKKBU-UHFFFAOYSA-N 0.000 description 1
- 238000000605 extraction Methods 0.000 description 1
- 238000001914 filtration Methods 0.000 description 1
- 239000007789 gas Substances 0.000 description 1
- 229960001340 histamine Drugs 0.000 description 1
- 229910000042 hydrogen bromide Inorganic materials 0.000 description 1
- 229910000041 hydrogen chloride Inorganic materials 0.000 description 1
- IXCSERBJSXMMFS-UHFFFAOYSA-N hydrogen chloride Substances Cl.Cl IXCSERBJSXMMFS-UHFFFAOYSA-N 0.000 description 1
- 238000000099 in vitro assay Methods 0.000 description 1
- 239000000543 intermediate Substances 0.000 description 1
- 238000001990 intravenous administration Methods 0.000 description 1
- 230000001665 lethal effect Effects 0.000 description 1
- 239000000463 material Substances 0.000 description 1
- 150000004682 monohydrates Chemical class 0.000 description 1
- 239000003960 organic solvent Substances 0.000 description 1
- 238000005192 partition Methods 0.000 description 1
- 239000003208 petroleum Substances 0.000 description 1
- 230000003285 pharmacodynamic effect Effects 0.000 description 1
- 239000002244 precipitate Substances 0.000 description 1
- 229960001404 quinidine Drugs 0.000 description 1
- 239000012429 reaction media Substances 0.000 description 1
- 230000036632 reaction speed Effects 0.000 description 1
- 230000009467 reduction Effects 0.000 description 1
- 238000010992 reflux Methods 0.000 description 1
- 229920006395 saturated elastomer Polymers 0.000 description 1
- 150000003335 secondary amines Chemical class 0.000 description 1
- 239000000741 silica gel Substances 0.000 description 1
- 229910002027 silica gel Inorganic materials 0.000 description 1
- 229910000030 sodium bicarbonate Inorganic materials 0.000 description 1
- 235000017557 sodium bicarbonate Nutrition 0.000 description 1
- 239000007787 solid Substances 0.000 description 1
- 239000012453 solvate Substances 0.000 description 1
- 239000002904 solvent Substances 0.000 description 1
- 230000003595 spectral effect Effects 0.000 description 1
- 238000004809 thin layer chromatography Methods 0.000 description 1
- 238000010626 work up procedure Methods 0.000 description 1
- 239000008096 xylene Substances 0.000 description 1
Landscapes
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Abstract
Vynález spadá do oboru syntetických léčiv. Jeho předmětem jsou 2-aminoalkylethery odvozené od 2-substituovaných 6,11-dihydrodibenzo(b,e)thiepin-ll-olů obecného vzorce I n fχ OCH2CH2 N___X (I) ve kterém R značí atom chloru nebo methyl a X je dvojmocný zbytek NH, NCH3, NCH2CH2OH, NCOOC2H5 nebo OH / C-.___, V CF, Cl a jejich soli s organickými kyselinami, s výhodou s kyselinou maleinovou. Tyto látky jsou antihistaminiky, antiarytmiky a antimikrobiálně účinnými látkami, takže přicházejí v úvahu pro praktické použití v terapii alergických onemocnění, poruch srdečního rytmu a v terapii mikrobiálních infekcí. Základním způsobem přípravy látek podle vynálezu jsou substituční reakce příslušných 11-(2-bromethoxy)sloučenin s aminy, tj. piperazinem a jeho příslušnými deriváty a 4-(4-chlor-3-trifluormethylfenyl)-4-piperidinolem. Neutralizací získaných bází organickými kyselinami se získají příslušné krystalické soli, z nichž jsou preferovány maleinátyThe invention is within the scope of synthetic drugs. Its subject is 2-aminoalkyl ethers derived from 2-substituted 6,11-dihydrodibenzo (b, e) thiepin-11-ol of formula (I) n fχ OCH2CH2 N___X (AND) wherein R is chlorine or methyl and X is a divalent radical of NH, NCH 3, NCH 2 CH 2 OH, NCOOC2H5 or OH / C-.___, In CF, Cl and their salts with organic acids, preferably maleic acid. These substances are antihistamines, antiarrhythmics and antimicrobials active ingredients, so they come for practical use in therapy allergic diseases, cardiac disorders rhythm and in the treatment of microbial infections. Basic by the method of preparing the compounds of the invention are the substitution reactions of the respective 11- (2-bromoethoxy) compounds with amines, i. piperazine and its corresponding derivatives a 4- (4-chloro-3-trifluoromethylphenyl) -4-piperidinol. Neutralization with organic base acids are obtained crystalline salts of which are preferred maleate
Description
Vynález se týká 2-aminoalkyletherů odvozených od 2-substituovaných 6,11-dihydrodibenzo(b,e)thiepin-ll-olů obeoného vzorce IThe present invention relates to 2-aminoalkyl ethers derived from 2-substituted 6,11-dihydrodibenzo (b, e) thiepin-11-oles of the obeonic formula I
H ÓCH2CH2fí X (X) ve kterém R značí atom chloru nebo methyl a X je dvojmocný zbytek NH, NCHj, NCH2CH2OH, NCOOCjHg nebo QH H OCH 2 CH 2 phi X (X) wherein R represents a chlorine atom or methyl and X is a divalent residue of NH, NCH 3 , NCH 2 CH 2 OH, NCOOC 3 H 6 or QH
Cl a jejich solí s organickými kyselinami, s výhodou s kyselinou maleinovou.Cl and their salts with organic acids, preferably maleic acid.
Látky podle vynálezu obeoného vzorce I jsou nové a vyznačují se některými typy farmakodynamické účinnosti, které jsou použitelné v terapii. V první řadě je to účinek antihistaminový, který z nich činí léčiva použitelná při alergických onemocněních. Dále je to účinek antirytmioký, použitelný v léčbě poruch srdečního rytmu. Konečně je to účinek antimikrobiálni v testech in vitro, který naznačuje použitelnost l£tek podle vynálezu v chemoterapii mikrobiálních infekcí. Uvedené účinky byly zjištěny v testech na pokusných zvířatech a jsou pro několik typických látek podle vynálezu dále uvedeny konkrétně.The compounds of the invention of formula (I) are novel and possess some types of pharmacodynamic activity that are useful in therapy. First of all, it is the antihistaminic effect that makes them useful in allergic diseases. Furthermore, it is an anti-rhythmic effect useful in the treatment of cardiac rhythm disorders. Finally, it is the antimicrobial effect in in vitro assays that indicates the usefulness of the compounds of the invention in the chemotherapy of microbial infections. These effects have been found in tests in experimental animals and are listed below specifically for several typical compounds of the invention.
2-chlor-ll-(2-piperazinoethoxy)-6,11-dihydrodibenzo(b,e)thiepin byl testován ve formě bis(hydrogenmaleinátu). Jeho akutní toxicita u myši při intravenózním podání, LD^g = 40 mg/ /kg. V dávce 8 mg/kg i.v. vykazuje látka antiarytmický účinek u krys vůči akonitinovým arytmiím, který je svou intenzitou srovnatelný s účinkem chinidinui- V téže dávce vyvolává látka krátkodobě a relativně hluboké poklesy krevního tlaku u normotensních krys. Inhibiční účinnost in vitro vůči následujícím mikroorganismům (uvedeny minimální inhibiční koncentrace v<ug/ml): Streptococcus beta-haemolyticus 25, Streptococcus faecalis 50, Staphylococcus pyogenes aureus 50, Escherichia coli 100, Trichophyton mentagrophytes 50.2-chloro-11- (2-piperazinoethoxy) -6,11-dihydrodibenzo (b, e) thiepine was tested in the form of bis (hydrogen maleate). Its acute toxicity in mice by intravenous administration, LD ^ g = 40 mg / / kg. At a dose of 8 mg / kg i.v. the compound exhibits an antiarrhythmic effect in rats against aconitine arrhythmias, which is comparable in intensity to that of quinidine. At the same dose, the compound produces short-term and relatively deep reductions in blood pressure in normotensive rats. In vitro inhibitory activity against the following microorganisms (minimum inhibitory concentrations in <µg / ml given): Streptococcus beta-haemolyticus 25, Streptococcus faecalis 50, Staphylococcus pyogenes aureus 50, Escherichia coli 100, Trichophyton mentagrophytes 50.
1-/2-(2-methyl-6,11-dihydrodibenzo(b,e)thiepin-11-yloxy)-ethyl/-4-(2-hydroxyethyl)piperazin byl testován rovněž jako bls/hydrogenmaleinát/. Jeho akutní toxicita u myší při orálním podání je velmi nízká; hodnota LD^g je vyšší než 2 g/kh. V orální dávce 5 mg/kg vykázala látka antihistaminový účinek u morčat (ochrana morčat před letálním účinkem dávky 5 mg/kg intrajugulárně podaného histaminu); intenzitou je to podobný efekt, jaký vykazuje p1- [2- (2-methyl-6,11-dihydrodibenzo (b, e) thiepin-11-yloxy) ethyl] -4- (2-hydroxyethyl) piperazine was also tested as bls (hydrogen maleate). Its acute toxicity in mice by oral administration is very low; LD 50 is greater than 2 g / kh. At an oral dose of 5 mg / kg, the compound showed an antihistamine effect in guinea pigs (protection of guinea pigs from the lethal effect of 5 mg / kg intrajugularly administered histamine); intensity, it is similar to p
mebrofenhydramin (Bromadryl ). V koncentraci 100 /ug/ml působí inhibičně na růst mikroorganismu Staphylococcus pyogenes aureus.mebrofenhydramine (Bromadryl). At a concentration of 100 µg / ml, it inhibits the growth of Staphylococcus pyogenes aureus.
1-/2 - (2-chlor-6,11-dihydrodibenzo (b, f) thiepin-ll-y,loxy) ethyl/-4- (4-chlor-3-trif luormethylfenyl) piperidin-4-ol byl testován ve formě hydrogenmalinátu.. Vykázal inhibiční účinnost in vitro vůči následujícím mikroorganismům (uvedeny minimální inhibiční koncentrace v ,ig/ml): Staphylococcus beta-haemolyticus 12,5, Streptococcus faecalis 100, Staphylococcus pyogenes aureus 25, Saccharomyces pasterianus 50, Trichophyton mentagrophytes 50.1- / 2- (2-chloro-6,11-dihydrodibenzo (b, f) thiepin-11-yloxy) ethyl] -4- (4-chloro-3-trifluoromethylphenyl) piperidin-4-ol was tested It exhibited inhibitory activity in vitro against the following microorganisms (minimum inhibitory concentrations in µg / ml given): Staphylococcus beta-haemolyticus 12.5, Streptococcus faecalis 100, Staphylococcus pyogenes aureus 25, Saccharomyces pasterianus 50, Trichophyton mentagrophytes 50.
Látky obecného vzorce I podle vynálezu jsou přístupné různými metodami, z nichž základní je substituční reakce 2-bromethyletherů obecného vzoroe IIThe compounds of the formula I according to the invention are accessible by various methods, the basic one being the substitution reaction of 2-bromoethyl ethers of the formula II
H OCH2CH2Bi ve kterém R značí totéž jako ve vzorci I, s příslušnými aminy, tj. s piperazinem, jeho Ν-methyl-, N-(2-hydroxyethyl)- a N-(ethoxykarbonyl)derivátem a dále s 4-(4-chlor-3-fluormethyl)-fenylpiperidin-4-olem. Tyto substituční reakce lze s výhodou provést ve většině případů v přebytku jmenovaných aminu, které pak slouží nejen jako reakční komponenta, ale též jako činidla odnímající bromovodík a konečně i jako reakční média. Reakce probíhají při zvýšených teplotách, tj. při 80 až 120 °C, přičemž uvedená horní hranice je z hlediska rychlosti reakce a výtěžnosti nejvýhodnější.H OCH 2 CH 2 Bi in which R denotes the same as in formula I, with the corresponding amines, i.e. piperazine, its Ν-methyl-, N- (2-hydroxyethyl) - and N- (ethoxycarbonyl) derivative and further with 4 - (4-chloro-3-fluoromethyl) phenylpiperidin-4-ol. These substitution reactions can advantageously be carried out in most cases in an excess of said amines, which then serve not only as the reaction component but also as hydrogen bromide scavengers and finally as reaction media. The reactions are carried out at elevated temperatures, i.e. at 80 to 120 ° C, with the upper limit being the most advantageous in terms of reaction speed and yield.
Substituční reakce lze provést též za použití ekvivalentu nebo jen malého přebytku aminů za přítomnosti uhličitanu draselného ve vroucím vhodném rozpouštědle, např. v ethanolu. Výchozí bromethylethery vzorce II jsou látky nové, jejichž příprava je popsána v příkladech. Sekundární aminy vzorce I, u nichž X = NH, lze připravit též alkalickou hydrolýzou karbamátů vzorce I, u nichž X = NCOC^Hg. Neutralizaci surových bází organickými kyselinami, s výhodou kyselinou maleinovou, se získají krystalické soli a jejich krystalizací se dosáhne vyčištění žádaných substanci. Alkalizací lze tyto čisté soli rozložit a extrakcí organickými rozpouštědly získat homogenní báze vzorce I.The substitution reactions can also be carried out using an equivalent or only a small excess of amines in the presence of potassium carbonate in a boiling suitable solvent, e.g. ethanol. The starting bromoethyl ethers of formula (II) are novel, the preparation of which is described in the examples. Secondary amines of formula I in which X = NH may also be prepared by alkaline hydrolysis of carbamates of formula I in which X = NCOC = Hg. Neutralization of the crude bases with organic acids, preferably maleic acid, yields crystalline salts and crystallizes them to purify the desired substances. By alkalization, these pure salts can be decomposed and extracted with organic solvents to obtain a homogeneous base of formula I.
Všechny nové látky v tomto vynálezu popsané, a to jak konečné produkty vzorce I, tak i meziprodukty, byly po stránce chemické identity zajištěny nejen analýzami, ale též všemi běžnými spektrálními metodami. Dále uvedené příklady mají za úkol ilustrovat možnosti přípravy látek podle vynálezu, avšak není jejich účelem popisovat všechny možné metody této přípravy.All of the novel compounds described in the present invention, both the end products of Formula I and intermediates, were assured not only by analysis but also by all conventional spectral methods in terms of chemical identity. The following examples are intended to illustrate the preparation possibilities of the compounds of the present invention, but are not intended to describe all possible methods of preparation.
Příklad 1Example 1
2-chlor-ll-/2-(4-methylpiperazino)ethoxy/-6,11-dihydrodibenzo(b,e)thiepin2-chloro-11- [2- (4-methylpiperazino) ethoxy] -6,11-dihydrodibenzo (b, e) thiepine
Směs 5,0 g 11-(2-bromethoxy)-2-chlor-6,11-dihydrodibenzo(b,e)thiepinu a 5,0 g 1-methylpiperazinu se míchá 5,5 h pod zpětným chladičem v lázni o teplotě 120 °C. Po ochlazení se směs zředí 30 ml 4% roztoku hydroxidu sodného a vyextrahuje chloroformem. Extrakt se promyje vodou, vysuší uhličitanem draselným a odpaří za sníženého tlaku. Zbytek se rozpustí v 25 ml ethanolu a teplý roztok se neutralizuje roztokem 3,5 g kyseliny raaleinové v 10 ml ethanolu. Stáním přes noc a filtrací se získá 7,5 g {89 %) bis/hydrogenmaleinátu/ žádané báze tající při 175 až 177 °C. Rekrystalizací z vodného methanolu se získá zcela čistá látka, t.t. 179 až 181 °C.A mixture of 5.0 g of 11- (2-bromoethoxy) -2-chloro-6,11-dihydrodibenzo (b, e) thiepine and 5.0 g of 1-methylpiperazine was stirred for 5.5 h under reflux in a 120 ° C bath. Deň: 32 ° C. After cooling, the mixture was diluted with 30 ml of 4% sodium hydroxide solution and extracted with chloroform. The extract was washed with water, dried over potassium carbonate and evaporated under reduced pressure. The residue was dissolved in 25 ml of ethanol and neutralized with a solution of 3.5 g of raaleic acid in 10 ml of ethanol. Standing overnight and filtration gave 7.5 g (89%) of the bis (hydrogen maleate) desired base melting at 175-177 ° C. Recrystallization from aqueous methanol gave the pure product, m.p. Mp 179-181 ° C.
Výchozí 11-(2-bromethoxy)-2-chlor-6,11-dihydrodibenzo(b,e)thiepin je nová a dosud nepopsaná látka, která se získá např. tímto postupem: Směs 25,0 g 2-chlor-6,1l-dihydrodibenzo(b,e)thiepin-ll-olu (Malen Ch. et al., NSR zveřejňovací spis 2 065 636), 250 ml benzenu,The starting 11- (2-bromoethoxy) -2-chloro-6,11-dihydrodibenzo (b, e) thiepine is a new and hitherto unwritten substance obtained, for example, by the following procedure: Mixture 25.0 g 2-chloro-6, 1l-dihydrodibenzo (b, e) thiepine-11-ol (Malen Ch. Et al., U.S. Pat. No. 2,065,636), 250 ml benzene,
18,0 g 2-bromethanolu a 1,75 ml kyseliny sírové se za míchání vaří 1 h pod zpětným chladičem. Po ochlazení se směs promyje vodou, 5% roztokem hydrogenuhličitanu sodného a znovu vodou, vysuší se síranem horečnatým a odpaří za sníženého tlaku. Zbytek se rozpustí v horkém benzenu, roztok se zfiltruje, k filtrátu se přidá petrolether a směs se ponechá krystalizaci za chladu. Stáním po dobu 24 h se vyloučí 31,1 g (88 %) žádaného čistého produktu tajícího při 90 až 92 °C.18.0 g of 2-bromoethanol and 1.75 ml of sulfuric acid are stirred and refluxed for 1 hour. After cooling, the mixture was washed with water, 5% sodium bicarbonate solution and again with water, dried over magnesium sulfate and evaporated under reduced pressure. The residue was dissolved in hot benzene, the solution was filtered, petroleum ether was added to the filtrate and the mixture was left to crystallize in the cold. On standing for 24 h, 31.1 g (88%) of the desired pure product melted at 90-92 ° C.
Příklad 2Example 2
2-chlor-ll-/2-(4-methylpiperazino)ethoxy/-6,11-dihydrodibenzo(b,e)thiepin2-chloro-11- [2- (4-methylpiperazino) ethoxy] -6,11-dihydrodibenzo (b, e) thiepine
Směs 5,0 g 11-(2-bromethoxy)-2-chlor-6,11-dihydrodibenzo(b,e)thiepinu /viz příklad 1/, 1,5 g 1-methylpiperazinu, 2,0 g uhličitanu draselného a 4 ml ethanolu se vaří 3 h pod zpětným chladičem. Po ochlazení se zředí vodou a extrahuje se chloroformem. Extrakt se protřepe s 25 ml ledově chladné a 1:4 zředěné kyseliny chlorovodíkové, vyloučená pevná látka se odfiltruje a filtrát se rozdělí. Kyselá vodná vrstva se alkalizuje vodným amoniakem a uvolněná báze se izoluje extrakcí etherem. Jako olej se získá ve výtěžku 2,4 g (46 %). Neutralizací pomocí 1,5 g kyseliny maleinové v ethanolu se získá 2,7 g bis/hydrogenmaleinátu/, který po krystalizaci z vodného methanolu taje při 179 až 181 °C a je identický s produktem získaným postupem v příkladu 1.A mixture of 5.0 g of 11- (2-bromoethoxy) -2-chloro-6,11-dihydrodibenzo (b, e) thiepine (see Example 1), 1.5 g of 1-methylpiperazine, 2.0 g of potassium carbonate, and 4 g. ml of ethanol was refluxed for 3 h. After cooling, it is diluted with water and extracted with chloroform. The extract is shaken with 25 ml of ice-cold and 1: 4 dilute hydrochloric acid, the precipitated solid is filtered off and the filtrate is separated. The acidic aqueous layer was basified with aqueous ammonia and the liberated base was isolated by extraction with ether. The oil was obtained in a yield of 2.4 g (46%). Neutralization with 1.5 g of maleic acid in ethanol gave 2.7 g of bis (hydrogen maleate) which, after crystallization from aqueous methanol, melts at 179-181 ° C and is identical to the product obtained in Example 1.
Příklad 3Example 3
2-methy1-11-/2-(4-methylpiperazino)ethoxy/-6,11-dihydrodibenzo(b,e)thiepin2-methyl-11- [2- (4-methylpiperazino) ethoxy] -6,11-dihydrodibenzo (b, e) thiepine
Směs 7,0 g 11-(2-bromethoxy)-2-methyl-6,11-dihydrodibenzo(b,e)thiepinu a 7,0 g 1-methylpiperazinu se míchá a zahřívá na 120 až 125 °C po dobu 4,5 h. Po stání přes noc se směs rozdělí mezi chloroform a 1:4 zředěný vodný amoniak, chloroformová vrstva se promyje vodou, vysuší síranem hořečnatým a odpaří za sníženého tlaku.'Zbytek se rozpustí v 70 ml teplého ethanolu a roztok se neutralizuje roztokem 6,5 g kyseliny maleinové ve 20 ml ethanolu.A mixture of 7.0 g of 11- (2-bromoethoxy) -2-methyl-6,11-dihydrodibenzo (b, e) thiepine and 7.0 g of 1-methylpiperazine is stirred and heated at 120 to 125 ° C for 4, After standing overnight, the mixture was partitioned between chloroform and 1: 4 dilute aqueous ammonia, the chloroform layer was washed with water, dried over magnesium sulfate and evaporated under reduced pressure. The residue was dissolved in 70 mL of warm ethanol and neutralized with 5 g of maleic acid in 20 ml of ethanol.
Vyloučí se 9,5 g (79 %) krystalického bis/hydrogenmaleinátu/, který taje při 166 až 169 °C. Čistá látka se získá rekrystalizací ze směsi vodného methanolu a acetonu, t.t. 174 až 175 °C.9.5 g (79%) of crystalline bis (hydrogen maleate) precipitate, melting at 166-169 ° C. The pure material was obtained by recrystallization from a mixture of aqueous methanol and acetone, m.p. Mp 174-175 ° C.
Použitý výchozí 11-(2-bromethoxy)-2-methyl-6,11-dihydrodibenzo(b,e)thiepin zatím nebyl v literatuře popsán. Lze jej získat dále uvedeným postupem: Směs 30,0 g 2-methyl-6,11-dihydrodibenzo (b,e) thiepin-ll-olu (Rajšner M. et al., Collect. Czech. Chem. Commun. 34, 1 015, 1969), 330 ml benzenu, 23,2 g 2-bromethanolu a 3,2 ml kyseliny sirové se zpracuje podobně, jak bylo v analogickém případě uvedeno v příkladu 1. Získá se 38,4 g (86 %) žádané látky, která krystaluje z benzenu jako 6:1 solvát s benzenem a taje při 108 až 110 °C (benzen-hexan).The starting 11- (2-bromoethoxy) -2-methyl-6,11-dihydrodibenzo (b, e) thiepine used has not been described in the literature. It can be obtained as follows: A mixture of 30.0 g of 2-methyl-6,11-dihydrodibenzo (b, e) thiepine-11-ol (Rajsner M. et al., Collect. Czech. Chem. Commun. 34, 1). 015 (1969), 330 ml of benzene, 23.2 g of 2-bromoethanol and 3.2 ml of sulfuric acid are treated in a similar manner to that described in Example 1. 38.4 g (86%) of the desired compound are obtained, which crystallizes from benzene as a 6: 1 benzene solvate and melts at 108-110 ° C (benzene-hexane).
Příklad 4Example 4
1-/2-(2-chlor-6,11-dihydrodibenzo(b,e)thiepin-11-yloxy)-ethyl/-4-(2-hydroxyethyl)piperazin1- [2- (2-chloro-6,11-dihydrodibenzo (b, e) thiepin-11-yloxy) ethyl] -4- (2-hydroxyethyl) piperazine
Směs 5,0 g 11-(2-bromethoxy)-2-chlor-6,11-dihydrodibenzo(b,e)thiepinu (viz příklad 1) a 5,5 g 1-(2-hydroxyethyl)piperazínu se míchá a zahřívá 5,5 h na 120 °C. Zpracuje se podobně jako v příkladu 1. Získá se 8,0 g (91 %) bis/hydrogenmaleinátu/ tajícího při 149 až 151 °C. Analytický vzorek se získá rekrystalizací ze směsi methanolu a etheru, t.t. 154 až 156 °C.A mixture of 5.0 g of 11- (2-bromoethoxy) -2-chloro-6,11-dihydrodibenzo (b, e) thiepine (see Example 1) and 5.5 g of 1- (2-hydroxyethyl) piperazine is stirred and heated 5.5 h at 120 ° C. Work up similar to Example 1. 8.0 g (91%) of bis (hydrogen maleate) melting at 149-151 ° C were obtained. An analytical sample was obtained by recrystallization from a mixture of methanol and ether, m.p. Mp 154-156 ° C.
Přiklad 5Example 5
1- /2-(2-methyl-6,11-dihydrodibenzo(b,e)thiepin-11-yloxy)ethyl/-4-(2-hydroxyethyl)piperazin1- [2- (2-methyl-6,11-dihydrodibenzo (b, e) thiepin-11-yloxy) ethyl] -4- (2-hydroxyethyl) piperazine
Reakcí 7,0 g 11-(2-bromethoxy)-2-methyl-6,11-dihydrodibenzo(b,e) thiepinu (viz příklad 3) se 7,0 g 1-(2-hydroxyethyl)piperazínu při 120 až 125 °C po dobu 4,5 h a podobným zpracováním jako v předešlém příkladu se získá 11,4 g (90 %) bis/hydrogenmaleinátu/, t.t. 153 až 154 °C (vodný methanol).Reaction of 7.0 g of 11- (2-bromoethoxy) -2-methyl-6,11-dihydrodibenzo (b, e) thiepine (see Example 3) with 7.0 g of 1- (2-hydroxyethyl) piperazine at 120-125 ° C for 4.5 h and similar treatment as in the previous example gave 11.4 g (90%) of bis (hydrogen maleate), m.p. 153-154 ° C (aqueous methanol).
Příkl· ad 6Example 6
2- chlor-ll-/2-(4-ethoxykarbonylpiperazino)ethoxy/-6,11-dihydrodibenzo(b,e)thiepin2-chloro-11- [2- (4-ethoxycarbonylpiperazino) ethoxy] -6,11-dihydrodibenzo (b, e) thiepine
Směs 10,0 g 11-(2-bromethoxy)-2-chlor-6,11-dihydrodibenzo(b,e)thiepinu (viz příklad 1) a 13,0 g 1-(ethoxykarbonyl)piperazínu se zahřívá 5,5 h na 120 °C. Po ochlazení se rozdělí mezi vodu a chloroform, chloroformová vrstva se promyje vodou a protřepe se studenou zředěnou kyselinou chlorovodíkovou. Oddělená vodná vrstva se ihned zalkalizuje 20% roztokem hydroxidu sodného a produkt se extrahuje chloroformem. Extrakt se vysuší uhličitanem draselným a odpaří za sníženého, tlaku, čímž se získá 11,2 g (93 %) žádané olejovité báze. Neutralizací kyselinou oxalovou poskytuje hydrogenoxalát, který krystaluje ze směsí ethanolu a etheru a taje při 172 až 173 °C.A mixture of 10.0 g of 11- (2-bromoethoxy) -2-chloro-6,11-dihydrodibenzo (b, e) thiepine (see Example 1) and 13.0 g of 1- (ethoxycarbonyl) piperazine was heated for 5.5 h. at 120 ° C. After cooling, partition between water and chloroform, wash the chloroform layer with water and shake with cold dilute hydrochloric acid. The separated aqueous layer was immediately basified with 20% sodium hydroxide solution and the product was extracted with chloroform. The extract was dried over potassium carbonate and evaporated under reduced pressure to give 11.2 g (93%) of the desired oil base. Neutralization with oxalic acid gives the hydrogen oxalate, which crystallizes from ethanol / ether mixtures and melts at 172-173 ° C.
Příklad 7Example 7
2-chlor-11-/2-(4-ethoxykarbonylpiperazino)ethoxy/-6,11-dihydrodibenzo(b,e)thiepin2-chloro-11- [2- (4-ethoxycarbonylpiperazino) ethoxy] -6,11-dihydrodibenzo (b, e) thiepine
Směs 5,0 g 2-chlor-6,11-dihydrodibenzo(b,e)thiepin-ll-olu (literatura citována) a 50 ml benzenu se sytí hodinu plynným chlorovodíkem. Benzen se potom odpaří ve vakuu, nahradí se 50 ml xylenu, přidají se 4,0 g l-ethoxykarbonyl-4-(2-hydroxyethyl)piperazinu (Moore T. S. et al., J. Chem. Soc. 1929, 39) a směs se vaří 5 h pod zpětným chladičem. Po ochlazení se promyje vodou, vysuší uhličitanem draselným a odpaří. Získá se 5,7 g (67 %) surové olejovité báze, jejíž neutralizací kyselinou oxalovou ve vodném ethanolu se získá hydrogenoxalát, který krystaluje též jako monohydrát, t.t. 167 až 168 °C (96% ethanol). Chromatografií na tenké vrstvě silikagelu lze prokázat identitu produktů, získaných podle 6. a 7. příkladu.A mixture of 5.0 g of 2-chloro-6,11-dihydrodibenzo (b, e) thiepine-11-ol (literature cited) and 50 ml of benzene is saturated with hydrogen chloride gas for 1 hour. The benzene is then evaporated in vacuo, replaced with 50 ml of xylene, 4.0 g of 1-ethoxycarbonyl-4- (2-hydroxyethyl) piperazine (Moore TS et al., J. Chem. Soc. 1929, 39) is added and the mixture was refluxed for 5 h. After cooling, it is washed with water, dried over potassium carbonate and evaporated. 5.7 g (67%) of a crude oily base are obtained, which is neutralized with oxalic acid in aqueous ethanol to give the hydrogen oxalate, which also crystallizes as the monohydrate, m.p. Mp 167-168 ° C (96% ethanol). Thin layer chromatography on silica gel showed the identity of the products obtained according to Examples 6 and 7.
Příklad 8Example 8
2-chlor-ll-(2-piperazinoethoxy)-6,11-dihydrodibenzo(b,e)thiepin2-chloro-11- (2-piperazinoethoxy) -6,11-dihydrodibenzo (b, e) thiepine
Směs 9,0 g olejovité báze 2-chlor-ll-/2-(4-ethoxykarbonylpiperazino)ethoxy/-6,11-dihydrodibenzo(b,e)thiepinu (viz příklady 6 a 7), 15 ml ethanolu a 10,0 g hydroxidu draselného se míchá a zahřívá pod zpětným chladičem 1 h v lázni vyhřáté na 120 °C. Po ochlazení se směs rozdělí mezi vodu a benzen, z benzenové vrstvy se báze extrahuje do 100 ml ledově chladné 5% kyseliny chlorovodíkové, oddělená vodná vrstva se zalkalizuje 20% roztokem hydroxidu sodného a báze se extrahuje benzenem. Extrakt se vysuší uhličitanem draselným a odpaří ve vakuu. Získá se 5,2 g (69 %) žádané olejovité báze, která neutralizací pomocí 3,3 g kyseliny maleinové ve 40 ml ethanolu poskytne 5,9 g krystalického bis/hydrogenmaleinátu/, t.t. 147 až 149 °C (ethanol) .A mixture of 9.0 g of oily base 2-chloro-11- [2- (4-ethoxycarbonylpiperazino) ethoxy] -6,11-dihydrodibenzo (b, e) thiepine (see Examples 6 and 7), 15 ml of ethanol and 10.0 g of potassium hydroxide was stirred and refluxed for 1 h in a bath heated to 120 ° C. After cooling, the mixture was partitioned between water and benzene, the base was extracted from the benzene layer into 100 ml of ice-cold 5% hydrochloric acid, the separated aqueous layer was basified with 20% sodium hydroxide solution and the base was extracted with benzene. The extract was dried over potassium carbonate and evaporated in vacuo. 5.2 g (69%) of the desired oily base are obtained which, by neutralization with 3.3 g of maleic acid in 40 ml of ethanol, yields 5.9 g of crystalline bis (hydrogen maleate), m.p. 147 DEG-149 DEG C. (ethanol).
Příklad 9Example 9
1-/2-(2-chlor-6,11-dihydrodibenzo(b,e)thiepin-11-yloxy)ethyl/-4-(4-chlor-3-trifluormethyl)piperidin-4-ol1- [2- (2-chloro-6,11-dihydrodibenzo (b, e) thiepin-11-yloxy) ethyl] -4- (4-chloro-3-trifluoromethyl) piperidin-4-ol
Směs 4,5 g 11-(2-bromethoxy)-2-chlor-6,11-dihydrodibenzo(b,e)thiepinu (viz příklad 1), 3,0 g 4-(4-chlor-3-trifluormethylfenyl)-4-piperidinolu (Šindelář K. et al., Collect. Czech. Chem. Commun. 38, 3 879, 1973) , 1,7 g uhličitanu draselného a 6 ml ethanolu se míchá a vaří 5 h pod zpětným chladičem. Po zředění 15 ml vody se směs extrahuje dichlormethanem, extrakt se vysuší uhličitanem draselným, zfiltruje s aktivním uhlím, a filtrát se odpaří ve vakuu. Zbytek se rozpustí v 15 ml ethanolu a roztok se neutralizuje roztokem 1,0 g kyseliny maleinové v 10 ml ethanolu. Získá se 5,5 g (75 %) hydrogenmaleinátu, který krystaluje ze směsi acetonu a etheru a taje při 201 až 203 °C.A mixture of 4.5 g of 11- (2-bromoethoxy) -2-chloro-6,11-dihydrodibenzo (b, e) thiepine (see Example 1), 3.0 g of 4- (4-chloro-3-trifluoromethylphenyl) - 4-piperidinol (Shindelar K. et al., Collect. Czech. Chem. Commun. 38, 3879, 1973), 1.7 g of potassium carbonate and 6 ml of ethanol are stirred and refluxed for 5 hours. After diluting with 15 ml of water, the mixture is extracted with dichloromethane, the extract is dried over potassium carbonate, filtered with charcoal, and the filtrate is evaporated in vacuo. The residue is dissolved in 15 ml of ethanol and neutralized with a solution of 1.0 g of maleic acid in 10 ml of ethanol. 5.5 g (75%) of hydrogen maleate are obtained, which crystallizes from a mixture of acetone and ether and melts at 201-203 ° C.
Claims (2)
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CS149684A CS237487B1 (en) | 1984-03-01 | 1984-03-01 | 2-aminoethyletheres derived from 2-substituted 6,11-dihydrodibenzo/b,e/thiepin-11-oles and salts of the same |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CS149684A CS237487B1 (en) | 1984-03-01 | 1984-03-01 | 2-aminoethyletheres derived from 2-substituted 6,11-dihydrodibenzo/b,e/thiepin-11-oles and salts of the same |
Publications (1)
Publication Number | Publication Date |
---|---|
CS237487B1 true CS237487B1 (en) | 1985-08-15 |
Family
ID=5349517
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CS149684A CS237487B1 (en) | 1984-03-01 | 1984-03-01 | 2-aminoethyletheres derived from 2-substituted 6,11-dihydrodibenzo/b,e/thiepin-11-oles and salts of the same |
Country Status (1)
Country | Link |
---|---|
CS (1) | CS237487B1 (en) |
-
1984
- 1984-03-01 CS CS149684A patent/CS237487B1/en unknown
Similar Documents
Publication | Publication Date | Title |
---|---|---|
US3058979A (en) | New perfluoroalkylphenothiazine derivatives | |
DE69701298T2 (en) | Hydroxypyridine derivatives, their preparation and their pharmaceutical use | |
JPS6264A (en) | Amides derived from quinoline, its production and pharmaceutical composition | |
US4603204A (en) | Theophylline derivatives | |
DE69111915T2 (en) | Pyrido (2,3-f) (1,4) thiazepine and pyrido (3,2-b) (1,5) benzothiazepine. | |
US3644366A (en) | 1-amino-3 4-dihydroisoquinolines | |
CS237487B1 (en) | 2-aminoethyletheres derived from 2-substituted 6,11-dihydrodibenzo/b,e/thiepin-11-oles and salts of the same | |
DE60201264T2 (en) | BENZOAXATHIEPINE DERIVATIVES AND THEIR MEDICAL USE | |
US2919272A (en) | Substituted phenothiazinyl trifluoromethyl sulfones | |
US4086244A (en) | Amidines | |
US4147871A (en) | Cyclohexanetetrol derivatives | |
EP0022481A1 (en) | 5,6-Alkylenepyrimidine derivatives, processes for preparing the same and pharmaceutical compositions | |
US4010161A (en) | Piperazinoethyl-N-(2,3-dimethyl-5-oxo-1-phenyl-3Δ-pyrazolin-4-yl)carbamates | |
US4261993A (en) | Indole derivatives | |
RU2026860C1 (en) | 3-CARBALKOXYAMINO-5-(α-AMINOPROPIONYL) -5H-DIBENZ-[B,F] -AZEP-INES SHOWING ANTIARRHYTMIC ACTIVITY | |
CS249455B1 (en) | N-substituted 2-chloro-7-fluoro-10-piperazino-10,11-dihydrodibenzo(b,f)thiepines and their salts and method of their preparation | |
CS257316B1 (en) | 1/4-cyclopentylphenyl/piperazines and their salts | |
CS237331B2 (en) | Processing of octahydropyrazole/3,4-g/chinoline | |
CS261295B1 (en) | Amidines and amidoximes of diphenylsulphide series and their salts | |
CS264933B1 (en) | Piperazines,their hydrochlorides and process for preparing them | |
CS256228B1 (en) | Method of new fluorinated 10-piperazino-10,11-dihydrodibenzo(b,f)-thiepine preparation | |
CS211326B1 (en) | 3,4-dichlor-11-piperazinodibenzol/b,f/zhiepins and the salts thereof | |
Lutz et al. | The Use of the Bromo-and Chloromethylation Reactions in the Synthesis of Some Dialkylaminomethyl-2, 5-diphenylfurans1 | |
CS236146B1 (en) | Method of diphenylsulphide series aminoalcohol preparation and of its dihydrochloride | |
CS268628B1 (en) | Method of n-(2-(2-chloro-10,11-dihydrodibenzo /b,f/-thietion |